The next step in incretin therapy: Dual GIP/GLP-1 receptor agonists
| Event title | Website of the event | Main speciality | Name of the CME provider | Nature of ELM | Expiration date |
|---|---|---|---|---|---|
| The next step in incretin therapy: Dual GIP/GLP-1 receptor agonists | Website | Endocrinology | Sciarc GmbH | Individual module | 08/11/2023 |
